BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Foegeding NJ, Caston RR, McClain MS, Ohi MD, Cover TL. An Overview of Helicobacter pylori VacA Toxin Biology. Toxins (Basel). 2016;8:pii: E173. [PMID: 27271669 DOI: 10.3390/toxins8060173] [Cited by in Crossref: 109] [Cited by in F6Publishing: 113] [Article Influence: 15.6] [Reference Citation Analysis]
Number Citing Articles
1 Reuter S, Raspe J, Uebner H, Contoyannis A, Pastille E, Westendorf AM, Caso GC, Cover TL, Müller A, Taube C. Treatment with Helicobacter pylori-derived VacA attenuates allergic airway disease. Front Immunol 2023;14. [DOI: 10.3389/fimmu.2023.1092801] [Reference Citation Analysis]
2 Svarval AV, Starkova DA, Ferman RS. Virulence determinants and genotypes of <i>Helicobacter pylori</i> clinical isolates. Journal of microbiology, epidemiology and immunobiology 2023;99:692-700. [DOI: 10.36233/0372-9311-298] [Reference Citation Analysis]
3 Kim Y, Boonyanugomol W, An W, Minh Phuong T, Park J, Shin M, Baik S, Lee W, Cho M, Kang H, Jung M. Regulation in the Expression of Virulence Factors of Helicobacter pylori by the Interaction between AGS Cells and H. pylori. J Bacteriol Virol 2022;52:160-169. [DOI: 10.4167/jbv.2022.52.4.160] [Reference Citation Analysis]
4 Kumar S, Mehrotra T, Talukdar D, Verma J, Chandra Karmakar B, Paul S, Chaudhuri S, Kumari Pragasam A, Bakshi S, Kumari S, Chawla M, Purohit A, Porey Karmakar S, Mutreja A, Banerjee S, Ray A, Ramamurthy T, Mukhopadyay AK, Das B. Region-specific genomic signatures of multidrug-resistant Helicobacter pylori isolated from East and South India. Gene 2022;847:146857. [PMID: 36100116 DOI: 10.1016/j.gene.2022.146857] [Reference Citation Analysis]
5 Ichiro Imoto, Satoko Oka, Masaki Katsurahara, Misaki Nakamura, Taro Yasuma, Junko Akada, Corina N. D’Alessandro-Gabazza, Masaaki Toda, Noriyuki Horiki, Esteban C. Gabazza, Yoshio Yamaoka. Helicobacter pylori infection: is there circulating vacuolating cytotoxin A or cytotoxin-associated gene A protein? Gut Pathog 2022;14:43. [PMID: 36463198 DOI: 10.1186/s13099-022-00519-8] [Reference Citation Analysis]
6 Almeida RS, Wisnieski F, Takao Real Karia B, Smith MAC. CRISPR/Cas9 Genome-Editing Technology and Potential Clinical Application in Gastric Cancer. Genes 2022;13:2029. [DOI: 10.3390/genes13112029] [Reference Citation Analysis]
7 Bisht N, P. Garg A. Helicobacter pylori Gastric Infection: Pathogenesis and Clinical Management. Helicobacter pylori Infection - An Up to Date on the Pathogenic Mechanisms, Diagnosis and Clinical Management [Working Title] 2022. [DOI: 10.5772/intechopen.106783] [Reference Citation Analysis]
8 Prada CF, Casadiego MA, Freire CC. Evolution of Helicobacter spp: variability of virulence factors and their relationship to pathogenicity. PeerJ 2022;10:e13120. [PMID: 36061745 DOI: 10.7717/peerj.13120] [Reference Citation Analysis]
9 Palframan SL, Mahmud MT, Tan KS, Grinter R, Xin V, Dunstan RA, Micati D, Kerr G, Mcmurrick PJ, Smith A, Abud H, Nguyen TN, Lazarou M, Kleifeld O, Lithgow T, Cover TL, Gabriel K, Gorrell RJ, Kwok T. Helicobacter pylori vacuolating cytotoxin A exploits human endosomes for intracellular activation.. [DOI: 10.1101/2022.08.22.504206] [Reference Citation Analysis]
10 Majewski M, Mertowska P, Mertowski S, Smolak K, Grywalska E, Torres K. Microbiota and the Immune System-Actors in the Gastric Cancer Story. Cancers (Basel) 2022;14:3832. [PMID: 35954495 DOI: 10.3390/cancers14153832] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Connolly SM, Erwin AL, Sabb M, Caso G, Cover TL, Ohi MD. Structural Analysis of Helicobacter pylori VacA's Channel in Membrane. Microsc Microanal 2022;28:1140-1. [DOI: 10.1017/s1431927622004792] [Reference Citation Analysis]
12 Wang L, Yi J, Yin X, Hou J, Chen J, Xie B, Chen G, Wang Q, Wang L, Wang X, Sun J, Huo L, Che T, Wei H. Vacuolating Cytotoxin A Triggers Mitophagy in Helicobacter pylori-Infected Human Gastric Epithelium Cells. Front Oncol 2022;12:881829. [DOI: 10.3389/fonc.2022.881829] [Reference Citation Analysis]
13 Clarke KR, Hor L, Pilapitiya A, Luirink J, Paxman JJ, Heras B. Phylogenetic Classification and Functional Review of Autotransporters. Front Immunol 2022;13:921272. [DOI: 10.3389/fimmu.2022.921272] [Reference Citation Analysis]
14 Lai C, Lin T, Huang M, Li S, Wu H, Chiu Y, Yang C, Chiu C, Lai H. Gut Commensal Parabacteroides goldsteinii MTS01 Alters Gut Microbiota Composition and Reduces Cholesterol to Mitigate Helicobacter pylori-Induced Pathogenesis. Front Immunol 2022;13:916848. [DOI: 10.3389/fimmu.2022.916848] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
15 Guo Q, Qin H, Liu X, Zhang X, Chen Z, Qin T, Chang L, Zhang W. The Emerging Roles of Human Gut Microbiota in Gastrointestinal Cancer. Front Immunol 2022;13:915047. [DOI: 10.3389/fimmu.2022.915047] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Nath AN, Retnakumar RJ, Francis A, Chhetri P, Thapa N, Chattopadhyay S. Peptic Ulcer and Gastric Cancer: Is It All in the Complex Host-Microbiome Interplay That Is Encoded in the Genomes of "Us" and "Them"? Front Microbiol 2022;13:835313. [PMID: 35547123 DOI: 10.3389/fmicb.2022.835313] [Reference Citation Analysis]
17 Svarval AV, Starkova DA, Ferman RS, Narvskaya OV. Genetic polymorphisms of <i>helicobacter pylori</i> clinical isolates in St. Petersburg, Russia. Russian Journal of Infection and Immunity 2022;12:315-322. [DOI: 10.15789/2220-7619-gpo-1744] [Reference Citation Analysis]
18 Vital JS, Tanoeiro L, Lopes-oliveira R, Vale FF. Biomarker Characterization and Prediction of Virulence and Antibiotic Resistance from Helicobacter pylori Next Generation Sequencing Data. Biomolecules 2022;12:691. [DOI: 10.3390/biom12050691] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
19 Brasil-costa I, Souza CDO, Monteiro LCR, Santos MES, Oliveira EHCD, Burbano RMR. H. pylori Infection and Virulence Factors cagA and vacA (s and m Regions) in Gastric Adenocarcinoma from Pará State, Brazil. Pathogens 2022;11:414. [DOI: 10.3390/pathogens11040414] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Doocey CM, Finn K, Murphy C, Guinane CM. The impact of the human microbiome in tumorigenesis, cancer progression, and biotherapeutic development. BMC Microbiol 2022;22. [DOI: 10.1186/s12866-022-02465-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
21 Sharndama HC, Mba IE. Helicobacter pylori: an up-to-date overview on the virulence and pathogenesis mechanisms. Braz J Microbiol 2022. [PMID: 34988937 DOI: 10.1007/s42770-021-00675-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 15.0] [Reference Citation Analysis]
22 Bai X, Zhu M, He Y, Wang T, Tian D, Shu J. The impacts of probiotics in eradication therapy of Helicobacter pylori. Arch Microbiol 2022;204:692. [PMID: 36344628 DOI: 10.1007/s00203-022-03314-w] [Reference Citation Analysis]
23 Lemichez E, Paillares E, Orth K, Kaval KG. Bacterial Protein Toxins as Tools in Cell Biology and Physiology. Reference Module in Life Sciences 2022. [DOI: 10.1016/b978-0-12-821618-7.00224-8] [Reference Citation Analysis]
24 Retnakumar R, Nath AN, Nair GB, Chattopadhyay S. Gastrointestinal microbiome in the context of Helicobacter pylori infection in stomach and gastroduodenal diseases. Progress in Molecular Biology and Translational Science 2022. [DOI: 10.1016/bs.pmbts.2022.07.001] [Reference Citation Analysis]
25 Caso GC, McClain MS, Erwin AL, Truelock MD, Campbell AM, Leasure CS, Nagel M, Schey KL, Lacy DB, Ohi MD, Cover TL. Functional Properties of Oligomeric and Monomeric Forms of Helicobacter pylori VacA Toxin. Infect Immun 2021;89:e0034821. [PMID: 34543122 DOI: 10.1128/IAI.00348-21] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Patricia Rendón-huerta E, Abraham García-garcía C, Felipe Montaño Estrada L. Effect of Helicobacter pylori on Tight Junctions in Gastric Epithelia. Helicobacter pylori - From First Isolation to 2021 2021. [DOI: 10.5772/intechopen.96607] [Reference Citation Analysis]
27 Papaefthymiou A, Christodoulidis G, Koffas A, Doulberis M, Polyzos SA, Manolakis A, Potamianos S, Kapsoritakis A, Kountouras J. Role of autophagy in gastric carcinogenesis. World J Gastrointest Oncol 2021; 13(10): 1244-1262 [PMID: 34721765 DOI: 10.4251/wjgo.v13.i10.1244] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
28 Hsu CY, Yeh JY, Chen CY, Wu HY, Chiang MH, Wu CL, Lin HJ, Chiu CH, Lai CH. Helicobacter pylori cholesterol-α-glucosyltransferase manipulates cholesterol for bacterial adherence to gastric epithelial cells. Virulence 2021;12:2341-51. [PMID: 34506250 DOI: 10.1080/21505594.2021.1969171] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Yuan LZ, Shi X, Tang D, Zheng SP, Xiao ZM, Wang F. Construction and preservation of a stable and highly expressed recombinant Helicobacter pylori vacuolating cytotoxin A with apoptotic activity. BMC Microbiol 2021;21:229. [PMID: 34407768 DOI: 10.1186/s12866-021-02262-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Kishk RM, Soliman NM, Anani MM, Nemr N, Salem A, Attia F, Allithy ANA, Fouad M. Genotyping of Helicobacter pylori Virulence Genes cagA and vacA: Regional and National Study. Int J Microbiol 2021;2021:5540560. [PMID: 34306090 DOI: 10.1155/2021/5540560] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
31 Linn AK, Samainukul N, Sakdee S, Butnampetch C, Li HC, Angsuthanasombat C, Katzenmeier G. N-Terminally Added Tag Selectively Enhances Heterologous Expression of VacA Cytotoxin Variants from Helicobacter pylori. Protein Pept Lett 2021;28:643-50. [PMID: 33183185 DOI: 10.2174/0929866527666201112122831] [Reference Citation Analysis]
32 Choudhury A, Ortiz P, Kearney CM. In situ treatment of H. pylori infection in mice stomach with bioengineered probiotic bacteria releasing guided Antimicrobial peptides.. [DOI: 10.1101/2021.06.11.448139] [Reference Citation Analysis]
33 Choudhury A, Ortiz P, Kearney CM. In vitro inhibition of H. pylori in a preferential manner using bioengineered L. lactis releasing guided Antimicrobial peptides.. [DOI: 10.1101/2021.06.11.448109] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
34 Santos S. Diagnosis and treatment of Helicobacter pylori infection with gastric ulceration: a case report. Gastrointestinal Nursing 2021;19:34-39. [DOI: 10.12968/gasn.2021.19.5.34] [Reference Citation Analysis]
35 Do AD, Chang CC, Su CH, Hsu YM. Lactobacillus rhamnosus JB3 inhibits Helicobacter pylori infection through multiple molecular actions. Helicobacter 2021;26:e12806. [PMID: 33843101 DOI: 10.1111/hel.12806] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
36 Rasi-Bonab F, Jafari-Sales A, Shaverdi MA, Navidifar T, Saki M, Ghorbani A, Adekanmbi AO, Jafari B, Naebi S. Antibiotic resistance pattern and frequency of cagA and vacA genes in Helicobacter pylori strains isolated from patients in Tabriz city, Iran. BMC Res Notes 2021;14:216. [PMID: 34059110 DOI: 10.1186/s13104-021-05633-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Loh JT, Shum MV, Jossart SDR, Campbell AM, Sawhney N, McDonald WH, Scholz MB, McClain MS, Forsyth MH, Cover TL. Delineation of the pH-Responsive Regulon Controlled by the Helicobacter pylori ArsRS Two-Component System. Infect Immun 2021;89:e00597-20. [PMID: 33526561 DOI: 10.1128/IAI.00597-20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
38 Saric A, Freeman SA. Endomembrane Tension and Trafficking. Front Cell Dev Biol 2020;8:611326. [PMID: 33490077 DOI: 10.3389/fcell.2020.611326] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
39 Vieira-pires RS, Morgan PM, Choraria A, Gandhimathi C, Michael A, Ôchoa-pires T, Salimian J, Rajan S, Subramani M. Applications of IgY in Human Medicine. IgY-Technology: Production and Application of Egg Yolk Antibodies 2021. [DOI: 10.1007/978-3-030-72688-1_16] [Reference Citation Analysis]
40 Thanaphongdecha P, Karinshak SE, Ittiprasert W, Mann VH, Chamgramol Y, Pairojkul C, Fox JG, Suttiprapa S, Sripa B, Brindley PJ. Infection with Helicobacter pylori Induces Epithelial to Mesenchymal Transition in Human Cholangiocytes. Pathogens 2020;9:E971. [PMID: 33233485 DOI: 10.3390/pathogens9110971] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
41 Sertbas M, Ulgen KO. Genome-Scale Metabolic Modeling for Unraveling Molecular Mechanisms of High Threat Pathogens. Front Cell Dev Biol 2020;8:566702. [PMID: 33251208 DOI: 10.3389/fcell.2020.566702] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
42 Boampong K, Smith SL, Delahay RM. Rapid growth inhibitory activity of a YafQ-family endonuclease toxin of the Helicobacter pylori tfs4 integrative and conjugative element. Sci Rep 2020;10:18171. [PMID: 33097748 DOI: 10.1038/s41598-020-72063-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
43 Roszczenko-Jasińska P, Wojtyś MI, Jagusztyn-Krynicka EK. Helicobacter pylori treatment in the post-antibiotics era-searching for new drug targets. Appl Microbiol Biotechnol 2020;104:9891-905. [PMID: 33052519 DOI: 10.1007/s00253-020-10945-w] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 9.0] [Reference Citation Analysis]
44 Khodadadi P, Kargar M, Bijanzadeh M, Doosti A, Aghaei S. Association of cagA, cagC, virB2, and vacA Subtypes of Helicobacter pylori with Adenocarcinoma Development in Iranian Patients. Jundishapur J Microbiol 2020;13. [DOI: 10.5812/jjm.101275] [Reference Citation Analysis]
45 Rakesh NR, Gurumurthy H, Pradeep HK, Pradeep S, Gurumurthy DM, Sachin CL. In-Silico Pharmacological and Molecular Docking Studies of Natural Inhibitors form Musa Spp. On Vaca Gene a Vacuolating Cytotoxin Autotransporter. IOP Conf Ser : Mater Sci Eng 2020;925:012051. [DOI: 10.1088/1757-899x/925/1/012051] [Reference Citation Analysis]
46 Mwangi C, Njoroge S, Tshibangu-Kabamba E, Moloo Z, Rajula A, Devani S, Matsumoto T, Nyerere K, Kariuki S, Revathi G, Yamaoka Y. Whole Genome Sequencing Reveals Virulence Potentials of Helicobacter pylori Strain KE21 Isolated from a Kenyan Patient with Gastric Signet Ring Cell Carcinoma. Toxins (Basel) 2020;12:E556. [PMID: 32872465 DOI: 10.3390/toxins12090556] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
47 Fiori-Duarte AT, Rodrigues RP, Kitagawa RR, Kawano DF. Insights into the Design of Inhibitors of the Urease Enzyme - A Major Target for the Treatment of Helicobacter pylori Infections. Curr Med Chem 2020;27:3967-82. [PMID: 30827224 DOI: 10.2174/0929867326666190301143549] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
48 Ansari S, Yamaoka Y. Role of vacuolating cytotoxin A in Helicobacter pylori infection and its impact on gastric pathogenesis. Expert Rev Anti Infect Ther 2020;18:987-96. [PMID: 32536287 DOI: 10.1080/14787210.2020.1782739] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
49 Chen X, Wang R, Bao C, Zhang J, Zhang J, Li R, Wu S, Wen J, Yang T, Wei S, Li H, Wei Y, Ren S, Zhao Y. Palmatine ameliorates Helicobacter pylori-induced chronic atrophic gastritis by inhibiting MMP-10 through ADAM17/EGFR. Eur J Pharmacol 2020;882:173267. [PMID: 32569674 DOI: 10.1016/j.ejphar.2020.173267] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
50 Singh A, Nayak N, Rathi P, Verma D, Sharma R, Chaudhary A, Agarwal A, Tripathi YB, Garg N. Microbiome and host crosstalk: A new paradigm to cancer therapy. Semin Cancer Biol 2021;70:71-84. [PMID: 32479952 DOI: 10.1016/j.semcancer.2020.05.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
51 Besednova NN, Kuznetsova TA, Zaporozhets TS, Kryzhanovsky SP, Gazha AK, Dobryakov EY, Zvyagintseva TN. The Influence of Polysaccharides from Sea Algae on the Pathogenetic Targets of <i>Helicobacter Pylori</i> — a New Direction in Therapy and Prevention of Infection. jour 2020;65:44-53. [DOI: 10.37489/0235-2990-2020-65-1-2-44-53] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
52 Caston RR, Sierra JC, Foegeding NJ, Truelock MD, Campbell AM, Frick-Cheng AE, Bimczok D, Wilson KT, McClain MS, Cover TL. Functional Properties of Helicobacter pylori VacA Toxin m1 and m2 Variants. Infect Immun 2020;88:e00032-20. [PMID: 32284370 DOI: 10.1128/IAI.00032-20] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
53 Szymczak A, Ferenc S, Majewska J, Miernikiewicz P, Gnus J, Witkiewicz W, Dąbrowska K. Application of 16S rRNA gene sequencing in Helicobacter pylori detection. PeerJ 2020;8:e9099. [PMID: 32440373 DOI: 10.7717/peerj.9099] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
54 Jangam D, Butzmann A, Sridhar K, Deresinski S, Banaei N, Shigeo Ohgami R. Significance of bacterial and viral genotypes as a risk factor in driving cancer (Review). Mol Clin Oncol 2020;13:3-12. [PMID: 32499911 DOI: 10.3892/mco.2020.2043] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
55 Sukhan DS, Vernygorodskyi SV, Haidukov NV, Ludkevich HP. Molecular and Genetic Aspects of Helicobacter pylori Interaction with Cells of Gastric Mucosa. Cytol Genet 2020;54:147-53. [DOI: 10.3103/s0095452720020139] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
56 Pachathundikandi SK, Blaser N, Bruns H, Backert S. Helicobacter pylori Avoids the Critical Activation of NLRP3 Inflammasome-Mediated Production of Oncogenic Mature IL-1β in Human Immune Cells. Cancers (Basel) 2020;12:E803. [PMID: 32230726 DOI: 10.3390/cancers12040803] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]
57 Lomovatskaya LA, Romanenko AS. Secretion Systems of Bacterial Phytopathogens and Mutualists (Review). Appl Biochem Microbiol 2020;56:115-129. [DOI: 10.1134/s0003683820020106] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
58 Sit WY, Chen YA, Chen YL, Lai CH, Wang WC. Cellular evasion strategies of Helicobacter pylori in regulating its intracellular fate. Semin Cell Dev Biol 2020;101:59-67. [PMID: 32033828 DOI: 10.1016/j.semcdb.2020.01.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
59 Zhang X, Arnold IC, Müller A. Mechanisms of persistence, innate immune activation and immunomodulation by the gastric pathogen Helicobacter pylori. Curr Opin Microbiol 2020;54:1-10. [PMID: 32007716 DOI: 10.1016/j.mib.2020.01.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
60 Ahmed M. Peptic Ulcer Disease. Digestive System - Recent Advances 2020. [DOI: 10.5772/intechopen.86652] [Reference Citation Analysis]
61 Gheorghe S, Negru Ş, Preda M, Mihai MM, Manolescu LSC, Popa MI, Stănculeanu DL. Microbiome implications in carcinogenesis initiation and promotion. Oncolog-Hematolog ro 2020;2:17. [DOI: 10.26416/onhe.51.2.2020.3188] [Reference Citation Analysis]
62 Isaeva GS. Pangenomic studies of Helicobacter pylori: a key to understanding pathogenesis and human history. Minerva Biotecnol 2019;31. [DOI: 10.23736/s1120-4826.19.02564-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
63 Sgouras D, Tegtmeyer N, Wessler S. Activity and Functional Importance of Helicobacter pylori Virulence Factors. Adv Exp Med Biol 2019;1149:35-56. [PMID: 31016624 DOI: 10.1007/5584_2019_358] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
64 Selvi R, Venkatachalam P, Rekha A, Dharaniya K, Ayesha S, Selvaraj R, Vijayaraghavan S. Helicobacter pylori Virulent Genes in the Upregulation of CCL20 and β-actin Expression and Progression towards Gastric Disorders. Journal of Microbiology and Infectious Diseases 2019. [DOI: 10.5799/jmid.614201] [Reference Citation Analysis]
65 Šterbenc A, Jarc E, Poljak M, Homan M. Helicobacter pylori virulence genes. World J Gastroenterol 2019;25:4870-84. [PMID: 31543679 DOI: 10.3748/wjg.v25.i33.4870] [Cited by in CrossRef: 68] [Cited by in F6Publishing: 69] [Article Influence: 17.0] [Reference Citation Analysis]
66 Knorr J, Ricci V, Hatakeyama M, Backert S. Classification of Helicobacter pylori Virulence Factors: Is CagA a Toxin or Not? Trends in Microbiology 2019;27:731-8. [DOI: 10.1016/j.tim.2019.04.010] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
67 Rolando M, Buchrieser C. A Comprehensive Review on the Manipulation of the Sphingolipid Pathway by Pathogenic Bacteria. Front Cell Dev Biol 2019;7:168. [PMID: 31497599 DOI: 10.3389/fcell.2019.00168] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
68 Zawilak-Pawlik A, Zarzecka U, Żyła-Uklejewicz D, Lach J, Strapagiel D, Tegtmeyer N, Böhm M, Backert S, Skorko-Glonek J. Establishment of serine protease htrA mutants in Helicobacter pylori is associated with secA mutations. Sci Rep 2019;9:11794. [PMID: 31409845 DOI: 10.1038/s41598-019-48030-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
69 Erwin AL, Su M, Campbell AM, Akey D, Lacy DB, Cover TL, Ohi MD. Structural Analysis of Helicobacter pylori VacA Reveals Insights into Oligomerization. Microsc Microanal 2019;25:1290-1291. [DOI: 10.1017/s1431927619007189] [Reference Citation Analysis]
70 Keikha M, Eslami M, Yousefi B, Ghasemian A, Karbalaei M. Potential antigen candidates for subunit vaccine development against Helicobacter pylori infection. J Cell Physiol 2019;234:21460-70. [DOI: 10.1002/jcp.28870] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 7.5] [Reference Citation Analysis]
71 Vesga FJ, Moreno Y, Ferrús MA, Ledesma-Gaitan LM, Campos C, Trespalacios AA. Correlation among fecal indicator bacteria and physicochemical parameters with the presence of Helicobacter pylori DNA in raw and drinking water from Bogotá, Colombia. Helicobacter 2019;24:e12582. [PMID: 30950129 DOI: 10.1111/hel.12582] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
72 Gutiérrez-Escobar AJ, Bravo MM, Acevedo O, Backert S. Molecular evolution of the VacA p55 binding domain of Helicobacter pylori in mestizos from a high gastric cancer region of Colombia. PeerJ 2019;7:e6634. [PMID: 31119065 DOI: 10.7717/peerj.6634] [Reference Citation Analysis]
73 Mony TJ, Kwon H, Won M, Kang Y, Lee S, Kim S, Baek D, Elahi F. Anti-urease immunoglobulin (IgY) from egg yolk prevents Helicobacter pylori infection in a mouse model. Food and Agricultural Immunology 2019;30:662-76. [DOI: 10.1080/09540105.2019.1617251] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
74 Capurro MI, Greenfield LK, Prashar A, Xia S, Abdullah M, Wong H, Zhong XZ, Bertaux-Skeirik N, Chakrabarti J, Siddiqui I, O'Brien C, Dong X, Robinson L, Peek RM Jr, Philpott DJ, Zavros Y, Helmrath M, Jones NL. VacA generates a protective intracellular reservoir for Helicobacter pylori that is eliminated by activation of the lysosomal calcium channel TRPML1. Nat Microbiol 2019;4:1411-23. [PMID: 31110360 DOI: 10.1038/s41564-019-0441-6] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 11.5] [Reference Citation Analysis]
75 Su M, Erwin AL, Campbell AM, Pyburn TM, Salay LE, Hanks JL, Lacy DB, Akey DL, Cover TL, Ohi MD. Cryo-EM Analysis Reveals Structural Basis of Helicobacter pylori VacA Toxin Oligomerization. J Mol Biol 2019;431:1956-65. [PMID: 30954575 DOI: 10.1016/j.jmb.2019.03.029] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
76 Zhang Z, Huang Q, Tao X, Song G, Zheng P, Li H, Sun H, Xia W. The unique trimeric assembly of the virulence factor HtrA from Helicobacter pylori occurs via N-terminal domain swapping. J Biol Chem 2019;294:7990-8000. [PMID: 30936204 DOI: 10.1074/jbc.RA119.007387] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
77 Foegeding NJ, Raghunathan K, Campbell AM, Kim SW, Lau KS, Kenworthy AK, Cover TL, Ohi MD. Intracellular Degradation of Helicobacter pylori VacA Toxin as a Determinant of Gastric Epithelial Cell Viability. Infect Immun 2019;87:e00783-18. [PMID: 30692181 DOI: 10.1128/IAI.00783-18] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
78 Neddermann M, Backert S. How many protein molecules are secreted by single Helicobacter pylori cells: Quantification of serine protease HtrA. Cellular Microbiology 2019;21. [DOI: 10.1111/cmi.13022] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
79 Krueger E, Brown AC. Inhibition of bacterial toxin recognition of membrane components as an anti-virulence strategy. J Biol Eng 2019;13:4. [PMID: 30820243 DOI: 10.1186/s13036-018-0138-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
80 Chauhan N, Tay ACY, Marshall BJ, Jain U. Helicobacter pylori VacA, a distinct toxin exerts diverse functionalities in numerous cells: An overview. Helicobacter 2019;24:e12544. [PMID: 30324717 DOI: 10.1111/hel.12544] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 12.5] [Reference Citation Analysis]
81 García-Zea JA, de la Herrán R, Robles Rodríguez F, Navajas-Pérez R, Ruiz Rejón C. Detection and variability analyses of CRISPR-like loci in the H. pylori genome. PeerJ 2019;7:e6221. [PMID: 30648020 DOI: 10.7717/peerj.6221] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
82 Kabamba ET, Yamaoka Y. Helicobacter pylori and Related Virulence Factors for Gastrointestinal Diseases. Gastric Cancer 2019. [DOI: 10.1007/978-981-13-1120-8_3] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
83 Whitmire JM, Merrell DS. Helicobacter pylori Genetic Polymorphisms in Gastric Disease Development. Advances in Experimental Medicine and Biology 2019. [DOI: 10.1007/5584_2019_365] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
84 F. Ghazi H, M. Fahad H, S. Mahmood A, J. Qasim B. Immunohistochemical Expression of Xenophagy Proteins in Helicobacter pylori and None Helicobacter pylori Gastritis. J Pure Appl Microbiol 2018;12:1795-1800. [DOI: 10.22207/jpam.12.4.12] [Reference Citation Analysis]
85 Mannion A, Shen Z, Fox JG. Comparative genomics analysis to differentiate metabolic and virulence gene potential in gastric versus enterohepatic Helicobacter species. BMC Genomics 2018;19:830. [PMID: 30458713 DOI: 10.1186/s12864-018-5171-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
86 Horridge DN, Begley AA, Kim J, Aravindan N, Fan K, Forsyth MH. Outer inflammatory protein a (OipA) of Helicobacter pylori is regulated by host cell contact and mediates CagA translocation and interleukin-8 response only in the presence of a functional cag pathogenicity island type IV secretion system. Pathog Dis. 2017;75. [PMID: 29040466 DOI: 10.1093/femspd/ftx113] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
87 Raghunathan K, Kenworthy AK. Dynamic pattern generation in cell membranes: Current insights into membrane organization. Biochim Biophys Acta Biomembr 2018;1860:2018-31. [PMID: 29752898 DOI: 10.1016/j.bbamem.2018.05.002] [Cited by in Crossref: 31] [Cited by in F6Publishing: 20] [Article Influence: 6.2] [Reference Citation Analysis]
88 Vesga F, Moreno Y, Ferrús MA, Campos C, Trespalacios AA. Detection of Helicobacter pylori in drinking water treatment plants in Bogotá, Colombia, using cultural and molecular techniques. International Journal of Hygiene and Environmental Health 2018;221:595-601. [DOI: 10.1016/j.ijheh.2018.04.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
89 Raghunathan K, Foegeding NJ, Campbell AM, Cover TL, Ohi MD, Kenworthy AK. Determinants of Raft Partitioning of the Helicobacter pylori Pore-Forming Toxin VacA. Infect Immun 2018;86:e00872-17. [PMID: 29531133 DOI: 10.1128/IAI.00872-17] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
90 Cassady-Cain RL, Hope JC, Stevens MP. Direct Manipulation of T Lymphocytes by Proteins of Gastrointestinal Bacterial Pathogens. Infect Immun 2018;86:e00683-17. [PMID: 29339462 DOI: 10.1128/IAI.00683-17] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
91 Backert S, Haas R, Gerhard M, Naumann M. The Helicobacter pylori Type IV Secretion System Encoded by the cag Pathogenicity Island: Architecture, Function, and Signaling. In: Backert S, Grohmann E, editors. Type IV Secretion in Gram-Negative and Gram-Positive Bacteria. Cham: Springer International Publishing; 2017. pp. 187-220. [DOI: 10.1007/978-3-319-75241-9_8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 34] [Article Influence: 5.2] [Reference Citation Analysis]
92 Kabamba ET, Tuan VP, Yamaoka Y. Genetic populations and virulence factors of Helicobacter pylori. Infect Genet Evol 2018;60:109-16. [PMID: 29471116 DOI: 10.1016/j.meegid.2018.02.022] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
93 Ricci V, Sommi P. Interaction of Helicobacter pylori VacA Toxin with Its Target Cells. Toxinology 2018. [DOI: 10.1007/978-94-007-6449-1_27] [Reference Citation Analysis]
94 Arora K. Advances in Nano Based Biosensors for Food and Agriculture. Environmental Chemistry for a Sustainable World 2018. [DOI: 10.1007/978-3-319-70166-0_1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
95 Tegtmeyer N, Backert S. Helicobacter pylori infection of AZ-521 cells reveals a type IV secretion defect and VacA-independent CagA phosphorylation. Dis Model Mech 2017;10:1539-40. [PMID: 29259027 DOI: 10.1242/dmm.032813] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
96 Hong KS, Ki MR, Ullah HMA, Lee EJ, Kim YD, Chung MJ, Elfadl AK, Park JK, Jeong KS. Preventive effect of anti-VacA egg yolk immunoglobulin (IgY) on Helicobacter pylori-infected mice. Vaccine 2018;36:371-80. [PMID: 29223485 DOI: 10.1016/j.vaccine.2017.11.082] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
97 Bangpanwimon K, Sottisuporn J, Mittraparp-Arthorn P, Ueaphatthanaphanich W, Rattanasupar A, Pourcel C, Vuddhakul V. CRISPR-like sequences in Helicobacter pylori and application in genotyping. Gut Pathog 2017;9:65. [PMID: 29177012 DOI: 10.1186/s13099-017-0215-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
98 McClain MS, Beckett AC, Cover TL. Helicobacter pylori Vacuolating Toxin and Gastric Cancer. Toxins (Basel). 2017;9. [PMID: 29023421 DOI: 10.3390/toxins9100316] [Cited by in Crossref: 67] [Cited by in F6Publishing: 67] [Article Influence: 11.2] [Reference Citation Analysis]
99 Foegeding NJ, Cover TL, Ohi MD. Characterizing the Intracellular Trafficking of Helicobacter pylori VacA. Microsc Microanal 2017;23:1362-1363. [DOI: 10.1017/s1431927617007474] [Reference Citation Analysis]
100 Robinson K, Letley DP, Kaneko K. The Human Stomach in Health and Disease: Infection Strategies by Helicobacter pylori. Curr Top Microbiol Immunol. 2017;400:1-26. [PMID: 28124147 DOI: 10.1007/978-3-319-50520-6_1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
101 Fahimi F, Tohidkia MR, Fouladi M, Aghabeygi R, Samadi N, Omidi Y. Pleiotropic cytotoxicity of VacA toxin in host cells and its impact on immunotherapy. Bioimpacts 2017;7:59-71. [PMID: 28546954 DOI: 10.15171/bi.2017.08] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
102 Backert S, Schmidt TP, Harrer A, Wessler S. Exploiting the Gastric Epithelial Barrier: Helicobacter pylori’s Attack on Tight and Adherens Junctions. In: Tegtmeyer N, Backert S, editors. Molecular Pathogenesis and Signal Transduction by Helicobacter pylori. Cham: Springer International Publishing; 2017. pp. 195-226. [DOI: 10.1007/978-3-319-50520-6_9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
103 Horvat A, Zaika AI. How does bacterial pathogen Helicobacter pylori control responses to cellular stress? Future Microbiol 2017;12:105-8. [PMID: 28111969 DOI: 10.2217/fmb-2016-0220] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
104 Hashinaga M, Suzuki R, Akada J, Matsumoto T, Kido Y, Okimoto T, Kodama M, Murakami K, Yamaoka Y. Differences in amino acid frequency in CagA and VacA sequences of Helicobacter pylori distinguish gastric cancer from gastric MALT lymphoma. Gut Pathog. 2016;8:54. [PMID: 27833662 DOI: 10.1186/s13099-016-0137-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
105 González-Rivera C, Campbell AM, Rutherford SA, Pyburn TM, Foegeding NJ, Barke TL, Spiller BW, McClain MS, Ohi MD, Lacy DB, Cover TL. A Nonoligomerizing Mutant Form of Helicobacter pylori VacA Allows Structural Analysis of the p33 Domain. Infect Immun 2016;84:2662-70. [PMID: 27382020 DOI: 10.1128/IAI.00254-16] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
106 Ricci V, Sommi P. Interaction of Helicobacter pylori VacA Toxin with Its Target Cells. Microbial Toxins 2016. [DOI: 10.1007/978-94-007-6725-6_27-1] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]